APA (7th ed.) Citation

T, M., A, K., O, M., P, H., T, B., EA, Ö., . . . U, P. (2026). Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy. JHEP reports : innovation in hepatology, 101943. https://doi.org/10.1016/j.jhepr.2026.101943

Chicago Style (17th ed.) Citation

T, Michler, et al. "Long-term Antigen Reduction Does Not Achieve Durable HBV Control in Mice but Enhances Therapeutic Vaccine Efficacy." JHEP Reports : Innovation in Hepatology 2026: 101943. https://doi.org/10.1016/j.jhepr.2026.101943.

MLA (9th ed.) Citation

T, Michler, et al. "Long-term Antigen Reduction Does Not Achieve Durable HBV Control in Mice but Enhances Therapeutic Vaccine Efficacy." JHEP Reports : Innovation in Hepatology, 2026, p. 101943, https://doi.org/10.1016/j.jhepr.2026.101943.